Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

PR Newswire

CAMBRIDGE, Mass., Nov. 20, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28th at 10:30 a.m. EST

The Piper Sandler Healthcare Conference will take place November 28November 30, 2023, in New York. 

A webcast of the fireside chat can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for approximately 90 days following the conference. 

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-piper-sandler-healthcare-conference-301992889.html

SOURCE Akebia Therapeutics

Copyright CNW Group 2023